Daiwa Securities Group Inc. - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 106 filers reported holding ASCENDIS PHARMA A/S in Q4 2018. The put-call ratio across all filers is 0.16 and the average weighting 1.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$258
+1.2%
2,754
-3.8%
0.00%0.0%
Q2 2023$255
-19.6%
2,862
-3.3%
0.00%0.0%
Q1 2023$317
-14.8%
2,959
-3.0%
0.00%
-33.3%
Q4 2022$372
-99.9%
3,051
+1.0%
0.00%0.0%
Q3 2022$312,000
+8.3%
3,022
-2.5%
0.00%
+50.0%
Q2 2022$288,000
-8.9%
3,098
+15.2%
0.00%0.0%
Q1 2022$316,000
+1.0%
2,689
+15.9%
0.00%0.0%
Q4 2021$313,000
-25.3%
2,321
-11.5%
0.00%
-33.3%
Q3 2021$419,000
+44.5%
2,623
+19.3%
0.00%
+50.0%
Q2 2021$290,000
-10.2%
2,198
-12.5%
0.00%0.0%
Q1 2021$323,000
-25.6%
2,512
-3.5%
0.00%
-33.3%
Q4 2020$434,000
+958.5%
2,602
+885.6%
0.00%
Q3 2020$41,000
+41.4%
264
+1.9%
0.00%
-100.0%
Q2 2020$29,0000.0%2590.0%0.00%
Q1 2020$29,000
-19.4%
2590.0%0.00%
Q4 2019$36,000
+28.6%
259
-11.0%
0.00%
Q3 2019$28,000
-15.2%
291
+2.5%
0.00%
Q2 2019$33,000
+10.0%
284
+10.9%
0.00%
Q1 2019$30,000
+76.5%
256
-7.6%
0.00%
Q4 2018$17,000
+30.8%
277
+56.5%
0.00%
Q3 2018$13,000
+8.3%
1770.0%0.00%
Q2 2018$12,0000.0%1770.0%0.00%
Q1 2018$12,0001770.00%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q4 2018
NameSharesValueWeighting ↓
RA Capital Management 5,865,338$978,221,00013.68%
Vivo Capital, LLC 1,797,745$299,828,00013.38%
Sofinnova Investments, Inc. 1,109,874$185,105,00011.02%
Avoro Capital Advisors LLC 1,800,000$300,204,0005.17%
Eventide Asset Management 1,704,148$284,218,0004.36%
Stenahm Asset Managment Ltd 29,000$4,837,0004.07%
Ghost Tree Capital, LLC 105,000$17,512,0003.90%
Eversept Partners, LP 187,043$31,195,0323.66%
Spyglass Capital Management LLC 701,594$117,012,0003.59%
Q Global Advisors, LLC 23,183$3,866,0002.72%
View complete list of ASCENDIS PHARMA A/S shareholders